RI
MXCT icon

Ridgewood Investments’s MaxCyte MXCT Stock Holding History

Ridgewood Investments’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$2.18K – 507
2025
Q2 		$2.18K Hold
1,000
– – ﹤0.01% 657
2025
Q1 		$2.73K Hold
1,000
– – ﹤0.01% 605
2024
Q4 		$4.16K Hold
1,000
– – ﹤0.01% 596
2024
Q3 		$3.89K Hold
1,000
– – ﹤0.01% 612
2024
Q2 		$3.92K Buy
+1,000
New +$4.3K ﹤0.01% 614

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ridgewood Investments's MXCT Position: Q3 2025 in Review

Ridgewood Investments sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 1,000 shares — an estimated $2.18K sold.

Ridgewood Investments first reported a position in MXCT in Q2 2024 and held it in 5 quarters. The position peaked at $4.16K in Q4 2024. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Ridgewood Investments reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Ridgewood Investments sold 1,000 MaxCyte shares in Q3 2025, an estimated $2.18K.
  • Ridgewood Investments first reported a position in MaxCyte in Q2 2024 and held it in 5 quarters.
  • Ridgewood Investments's MaxCyte position peaked at $4.16K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.